Skip to main content
. 2022 Apr 19;13:863177. doi: 10.3389/fimmu.2022.863177

Figure 2.

Figure 2

Overview of treatment course. Platelet count (in K/µl, solid line) and CD20+ B-cell count (in cells/µl, dotted line) from beginning of presentation until hospital discharge is shown. Symptom onset is shown on top, while therapies are shown on bottom with corresponding arrows. This demonstrates rapid B-cell depletion following obinutuzumab therapy with gradual rise in platelet count.